Insulin Resistance Intervention after Stroke (IRIS) Trial 2013-2014

  • Pettigrew, Luther (PI)

Grants and Contracts Details


to determine if pioglitazone, compared to placebo, will reduce the overall risk for fatal or non-fatal stroke or fatal or non-fatal MI among non-diabetic men and women over age 40 years with insulin resistance and a recent ischemic stroke or transient ischemic attack.
Effective start/end date9/1/128/31/14


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.